| Clinical data | |
|---|---|
| Other names | NSC-33170; Chloroacetoxyprogesterone; CAP; 6α-Chloro-17α-acetoxyprogesterone; 6α-Chloro-17α-acetoxypregn-4-ene-3,20-dione |
| Drug class | Progestogen;Progestogen ester |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.124.835 |
| Chemical and physical data | |
| Formula | C23H31ClO4 |
| Molar mass | 406.95 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Hydromadinone acetate (developmental code nameNSC-33170), also known aschloroacetoxyprogesterone (CAP), as well as6α-chloro-17α-acetoxyprogesterone or6α-chloro-17α-acetoxypregn-4-ene-3,20-dione, is asteroidalprogestin of the17α-hydroxyprogesterone group that was never marketed.[1][2] It is the C17αacetateester ofhydromadinone, which, similarly, was never marketed.[1]
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |